Establishing the Irish Critical Care Trials Group: 'who wins in battle makes many calculations before the battle is fought' by O'Brien, Brian & Phelan, Dermot
Page 1 of 2
(page number not for citation purposes)
Available online http://ccforum.com/content/12/5/183
Abstract
Quality research, requiring large numbers of participants, in the
intensive care unit (ICU) population requires multicentre collabora-
tion. Although logistically challenging, this methodology reduces
the influence of individual units and has greater validity and broader
relevance to patients and practitioners. The nascent Irish Critical
Care Trials Group opens additional such opportunities. In the
accompanying epidemiologic study, the group present data
gathered over 10 weeks of 2006 describing 1,029 patients, from
10 Irish ICUs representing over one-half of Ireland’s critical care
bed capacity. The data depict a busy service, with 78% of
admissions being emergent and with a moderately high (7%)
readmission rate. While recognising that there were missing data,
the outcomes in organ failure and sepsis – where international
definitions exist – and the ICU survival rate (83%) were consistent
with international standards. The achievement of this planned first
epidemiological step lays the foundation for the conduct of
prospective scientific studies. These studies might occur in Ireland
or in cooperation with other audit/scientific groups such as the
UK’s Intensive Care National Audit and Research Centre, the
European Critical Care Research Network, or others. This brings
us a small step closer to the prospect of global, high-volume
studies in critical care.
Who wins in battle makes many calculations 
before the battle is fought.
(Sun Tzu, The Art of War, c.500 BC)
The challenge of conducting high-quality clinical studies in
the critically ill population is widely recognised. Heterogeneity
in patient populations and clinical practice, diagnostic
uncertainty, concerns with consent, and the overlapping
nature of the presenting illnesses are amongst the inherent
difficulties. Influential studies in this population therefore
increasingly involve multicentre, collaborative efforts using
rigorously defined inclusion criteria and outcome measures –
such projects aim to obviate the aforementioned difficulties
and to reduce the influence of individual intensive care units
(ICUs) and case-mix variations on the findings. Ultimately, the
quality of the data justifies the logistical challenge involved.
For this reason, the recent article from the newly-formed Irish
Critical Care Trials Group is a welcome announcement of a
further such alliance [1].
The data presented describe 1,029 patients admitted to ICU
services in a 10-week period in 2006, covering a slight
majority of all ICU beds in Ireland. The data include national
specialist centres and university teaching hospitals, as well as
regional units. The overall pattern depicts a busy service, with
78% of admissions being emergent in nature, a mean
Sequential Organ Failure Assessment score of 5.4, and 70%
of patients needing mechanical ventilation. Previous research
in Ireland – showing an ICU bed occupancy rate of 97%, an
unscheduled discharge rate of 23%, and frequent cancel-
lation of elective surgery – is consistent with this pattern [2].
The ICU readmission rate of 7.5% is perhaps attributable to
these service realities – as indeed may be the failure to
collect data in four of the 14 units that entered the study,
including 23% of relevant patients.
While accepting that the missing patient data compromise the
validity of the findings, the outcomes nonetheless appear
compatible with international standards and indeed are broadly
indicative of the success of modern intensive care medicine.
More than 80% of patients survived their ICU stay. The
outcomes in the subgroups are more striking: over 75% of
readmitted patients survived and, of the 93 patients with five or
six systems failing on admission, just over one-half survived.
Compatibility with international outcomes is perhaps most
evident from those diagnostic categories where standard,
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consensus definitions are established. For severe sepsis, the
ICU mortality of 24% compares with a reported 35% in
England, Wales and Northern Ireland for severe sepsis in the
first 24 hours [3]. For acute lung injury/acute respiratory
distress syndrome, the Irish mortality was 32% – and the Irish
Critical Care Trials Group has previously shown that this is
consistent with modern international studies in the protective
ventilation era [4]. Although the numbers are relatively small
(n = 289), an ICU mortality of 38% for renal failure compares
unfavourably with the hospital mortality of 26.3% reported by
Hoste and colleagues using the same criteria [5]. Nonethe-
less, the study arguably further validates these RIFLE (Risk-
Injury-Failure-Loss-End stage) descriptors as outcome predic-
tors in acute renal dysfunction [5].
Certain shortcomings are inevitable in this research format.
Seasonal and regional variations cannot be detected as data
from a short collection period are pooled together. Nothing
can be inferred about decision-making processes. The use of
ICU mortality alone as a measure of outcome is not ideal, and
more meaningful outcome assessment tools including
hospital mortality should be utilised in future projects [6]; for
example, patients who were refused readmission and who
might have gone on to die in hospital wards will appear as
survivors in such a crude analysis. Future scientific publica-
tions should also avoid the irritation of new data introduction
in the discussion of the findings.
The value of the present data will be more fully realised when
the Irish Critical Care Trials Group produces further,
hypothesis-testing studies. Having taken advice from the
ANZICS Critical Care Trials Group, the Irish Critical Care
Trials Group set out to achieve this epidemiological study to
provide baseline information for research planning. The data
provide insight into disease prevalence (for example, of acute
respiratory distress syndrome), and enable planning for the
study duration and resource allocation once power analysis
has indicated the size of the study population required. The
demonstration of the willingness of team members to
cooperate and of the capacity of information systems to
gather and collate such information is a further key to such
studies and collaborations.
The authors identify an urgent requirement for audit
resources to maintain the ambition shown by this study.
Participation in the UK’s Intensive Care National Audit and
Research Centre would be one option, opening up the
possibility of a UK/Irish database. Alternatively, broader inter-
national collaborations might work. The ability demonstrated
by the Irish Critical Care Trials Group study to establish a
research ethos that straddles the relatively contentious
border linking the Irish Republic with the United Kingdom is
scientifically encouraging.
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